![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.ajibio-pharma.com/news-post/ajinomoto-bio-pharma-services-announces-the-approval-of-the-32nd-drug-product-at-their-san-diego-sterile-fill-finish-site/
https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-garners-six-cdmo-leadership-awards-further-establishing-its-industry-excellence-302085856.html
https://www.europeanpharmaceuticalreview.com/news/188781/new-acquisition-to-support-global-gene-therapy-manufacturing/
https://www.contractpharma.com/contents/view_breaking-news/2023-05-18/ajinomoto-bio-pharma-services-announces-leadership/?widget=listSection
https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-receives-fda-approval-for-high-potency-fill-line-301801108.html
https://www.ajibio-pharma.com/news-post/ajinomoto-bio-pharma-services-awarded-three-cdmo-leadership-awards/
https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-successfully-develops-highly-functional-ancestral-rna-ligase-301752133.html
https://www.prnewswire.com/news-releases/ajinomoto-and-exelixis-enter-into-a-license-agreement-to-discover-and-develop-novel-antibody-drug-conjugates-for-the-treatment-of-cancer-301717135.html
https://www.ajibio-pharma.com/news-post/ajinomoto-bio-pharma-services-awarded-two-cmo-leadership-awards/
https://www.prnewswire.com/news-releases/tony-oneill-joins-ajinomoto-bio-pharma-services-leadership-team-as-vice-president-of-compliance-301467205.html